This appears to be an application to patent a new DNAWitness product, to be held by Gabriel, Frudakis, and a Matthew Thomas.
Is there any possibility that these guys are trying to move on with DNAWitness for themselves, leaving DNAG, and it's equity and debt holders behind? If I was a major shareholder, I would be all over this.